Literature DB >> 11709446

Behçet's disease and thrombophilia.

M Leiba1, Y Sidi, H Gur, A Leiba, M Ehrenfeld.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11709446      PMCID： PMC1753444          DOI： 10.1136/ard.60.12.1081

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  54 in total

1.  Procoagulant mutations and venous thrombosis in Behçet's disease.

Authors:  A Gül; A B Aslantas; T Tekinay; M Koniçe; T Ozçelik
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

Review 2.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

3.  Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?

Authors:  R Priori; F Conti; V Pittoni; T Garofalo; M Sorice; G Valesini
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

Review 4.  Antiphospholipid antibodies and thrombosis.

Authors:  M Greaves
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

5.  Hyperhomocysteinaemia and activated protein C resistance in Behçet's disease.

Authors:  A Altinbaş; K Aytemur; L Tokgözoğlu; M Oztürk; A Koşar; I C Haznedaroğlu; S Kirazli; S V Dündar
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

6.  Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.

Authors:  R Mader; M Ziv; M Adawi; R Mader; I Lavi
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

7.  Haemostasis in patients with Behçet's disease.

Authors:  S Demirer; N Sengül; M A Yerdel; A Tüzüner; A T Ulus; A Gürler; D Bergqvist; A Siegbahn; S Karacagil
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-06       Impact factor: 7.069

8.  Factor V Leiden mutation is associated with ocular involvement in Behçet disease.

Authors:  D H Verity; R W Vaughan; W Madanat; E Kondeatis; H Zureikat; F Fayyad; C A Kanawati; I Ayesh; M R Stanford; G R Wallace
Journal:  Am J Ophthalmol       Date:  1999-09       Impact factor: 5.258

9.  Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.

Authors:  M Nalçaci; Y Pekçelen
Journal:  J Int Med Res       Date:  1998 Aug-Sep       Impact factor: 1.671

10.  Vasculo-Behçet's disease: immunological study of the formation of aneurysm.

Authors:  K Yamana; K Kosuga; H Kinoshita; K Uraguchi; T Kinoshita; Y Hirata; H Akashi; T Nakayama; K Ohishi
Journal:  J Cardiovasc Surg (Torino)       Date:  1988 Nov-Dec       Impact factor: 1.888
View more
  18 in total

1.  Serum homocysteine level is higher in Behçet's disease with vascular involvement.

Authors:  Aşkin Ateş; Olcay Aydintuğ; Umit Olmez; Nurşen Düzgün; Murat Duman
Journal:  Rheumatol Int       Date:  2003-10-30       Impact factor: 2.631

2.  An atypical vascular case of Behçet's disease and consequent treatment.

Authors:  Raffaella Benedetti; Alessandro Brignone; Leonardo Incerti Vecchi; Francesco Orlandini
Journal:  Intern Emerg Med       Date:  2008-12-12       Impact factor: 3.397

3.  Reply to Stoimenis et al.

Authors:  Burcu Bakir-Gungor; Elaine F Remmers; Akira Meguro; Nobuhisa Mizuki; Daniel L Kastner; Ahmet Gul; Osman Ugur Sezerman
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

4.  Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease.

Authors:  N Şule Yaşar; Füsun Salgür; Döndü Ü Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

5.  Deep venous thrombosis in a patient with Behçet's disease and homozygous prothrombin (factor II) G20210A mutation on oral contraceptive pills.

Authors:  Imad Uthman; Zaher Otrock; Ali Taher
Journal:  Rheumatol Int       Date:  2005-09-28       Impact factor: 2.631

6.  [Behçet's disease].

Authors:  I Kötter; T Xenitidis; G Fierlbeck; S Schanz; A Melms; M Horger; U Ernemann; C Deuter
Journal:  Z Rheumatol       Date:  2012-10       Impact factor: 1.372

7.  Thrombosis in Behçet's disease: a Behçet's disease patient with complete thrombotic obstruction of IVC and both iliac veins and decreased protein S activity.

Authors:  Harin Jeong; In-Kyung Yoo; Sungjae Choi; Youngho Lee; Jongdae Ji; Gwankyu Song; Hwanhoon Chung; Seunghwa Lee; Won-Min Jo
Journal:  Rheumatol Int       Date:  2011-12-27       Impact factor: 2.631

8.  Deep vein and intracardiac thrombosis during the post-partum period in Behçet's disease.

Authors:  Prashant Hiwarkar; Roberto Stasi; George Sutherland; Muriel Shannon
Journal:  Int J Hematol       Date:  2010-03-10       Impact factor: 2.490

9.  Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease.

Authors:  N Düzgün; T Duman; Y Morris; H Tutkak; K Köse; E Ertuğrul; O Tiryaki Aydintuğ
Journal:  Clin Rheumatol       Date:  2008-05-06       Impact factor: 2.980

10.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.